Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04831866 · ClinicalTrials.gov registry record
COVID-19 Surveillance and Exposure Testing in School Communities
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 4,000
- Enrollment target
NCT04831866: Completed study, sponsored by Duke University.
NCT04831866 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 4,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04831866 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
Study Summary
This is a prospective, observational study of COVID-19 surveillance and exposure testing in school communities. Participating school communities are providing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests to students and staff at their schools per school, local, and national guidelines. This study will combine data received from the schools with data collected directly from participants to guide analysis of the co-primary objectives. Participants will be grouped into two different cohorts, depending on each school's SARS-CoV-2 test administration practices. Surveillance Cohort: Schools participating in this cohort will be performing surveillance testing weekly on approximately 10-20% of students and 100% of staff. Exposure Cohort: Schools participating in this cohort will be performing exposure testing on students and staff who have been identified as having close contact with school members diagnosed with SARS-CoV-2 infection.
Primary Outcome
Proportion of students/staff with positive SARS-CoV-2 test identified by surveillance testing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2021-04-26 |
| Est. Completion | 2022-01-31 |
What the finished NCT04831866 record still lists
NCT04831866 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04831866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04831866 about?
NCT04831866 is a clinical study titled "COVID-19 Surveillance and Exposure Testing in School Communities". This is a prospective, observational study of COVID-19 surveillance and exposure testing in school communities. Participating school communities are providing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests to students and staff at their schools per school, local, and national gui...
What is the current status of trial NCT04831866?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 2021-04-26. Estimated completion is 2022-01-31.
Who is sponsoring clinical trial NCT04831866?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI